Health Care · Pharmaceutical Preparations · Nasdaq · CIK 1985062 · FYE Mar 31 · Prices AT CLOSE 2026-07-29 (USD) — end-of-day, never a live or intraday quote
Last $2.98Day −5.70%1Y −98.9%Off 52W high −99.2%Vol (1Y) 227.1%
Daily closing price, split-adjusted to the current basis; 2.4y shown of 617 bars on file. Sampled to 240 points — every point is a real close, none averaged. Price return, not total return (dividends excluded). Source marketstack.
| Short interest1.3% of sh out |
| Days to cover1.0d |
| 13F net flow (QoQ)+0.00% |
| Top-10 13F concentration100.0% |
Short interest is FINRA semi-monthly, settlement 2026-07-15. 13F figures are quarterly filings, period 2026-Q1 — a lower bound on true ownership.
| Earnings (TTM)$1.0M |
Screener basis: ratios from the latest reported fiscal year; Sales/Earnings are trailing twelve months in the reporting currency (USD). The P/E is a trailing FULL-YEAR P/E, not TTM. Missing lines are absent from the filings, never imputed.
| YTD−89.9% |
| 1Y−98.9% |
| Since incept. (ann.)−98.0% |
Total return through 2026-07-29 · series begins 2024-01-26. Only the windows this history actually covers are shown.
| Ann. volatility (1Y)227.1% |
| Ann. volatility (3Y)197.2% |
| Sharpe (1Y)−0.90 |
| Sharpe (3Y)−1.01 |
| Max drawdown (1Y)−99.4% |
| Max drawdown (3Y)−100.0% |
| Beta (3Y vs SPY)5.80 |
Daily simple returns, annualized; drawdown is peak-to-trough within the window. Beta is the OLS slope of monthly returns on SPY's over three years. Each figure is labeled by the window it was measured over — they are not comparable across windows.
| Manager | Shares | Value | % sh out | QoQ |
|---|---|---|---|---|
| Parallel Advisors, LLC | 151,250 | $574,750 | 6.60% | +0.0% |
| Stonehage Fleming Financial Services Holdings Ltd | 89 | $218 | 0.00% | new |
Reported 13F long positions as filed for 2026-Q1 (change vs 2025-Q4). 13F covers US-listed long equity only — the sum is a LOWER BOUND on institutional ownership, never a total.
No reported quarters on file for PBM.
